ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5448-5456

  Akbari, Omid ^a   Stock, Philippe ^b   Meyer, Everett H ^c   Freeman, Gordon J ^d   Sharpe, Arlene H ^e   Umetsu, Dale T ^a   Dekruyff, Rosemarie H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c STANFORD UNIVERSITY   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDUCIBLE COSTIMULATOR PROTEIN; INDUCIBLE COSTIMULATORY LIGAND; INTERLEUKIN 13; INTERLEUKIN 4; LIGAND; PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; ICOSL PROTEIN, MOUSE; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOMEOSTASIS; LIVER; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SPLEEN; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LIGANDS; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 45949091620     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5448     Document Type: Article

References (45)

1. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergeninduced airway hyperreactivity. Nat. Med. 9: 582-588.
2. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J. M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant V α 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171: 1637-1641.
3. Jin, N., N. Miyahara, C. L. Roark, J. D. French, M. K. Aydintug, J. L. Matsuda, L. Gapin, L. O'Brien, E. W. Gelfand, and W. K. Born. 2007. Airway Hyperresponsiveness through Synergy of γδ T Cells and NKT Cells. J. Immunol. 179: 2961-2968.
4. + T cells. Proc. Natl. Acad. Sci. USA 103: 2782-2787.
5. Kim, J.-O., D.-H. Kim, W.-S. Chang, C. Hong, S.-H. Park, S. Kim, and C.-Y. Kang. 2004. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 114: 1332-1338.
6. Kim, D. H., W. S. Chang, Y. S. Lee, K. A. Lee, Y. K. Kim, B. S. Kwon, and C. Y. Kang. 2008. 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation. J. Immunol. 180: 2062-2068.
7. Pichavant, M., S. Goya, E. H. Meyer, R. A. Johnston, H. Y. Kim, P. Matangkasombut, M. Zhu, Y. Iwakura, P. B. Savage, R. H. Dekruyff, et al. 2008. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 205: 385-393.
8. Matangkasombut, P., M. Pichavant, T. Yasumi, C. Hendricks, P. B. Savage, R. H. DeKruyff, and D. T. Umetsu. 2008. Direct activation of NK T cells induces airway-hyperreactivity in nonhuman primates. J. Allergy Clin. Immunol. In press.
9. + natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129.
10. + T cells upon CD226 engagement. J. Immunol. 175: 4914-4926.
11. Vijayanand, P., G. Seumois, C. Pickard, R. M. Powell, G. Angco, D. Sammut, S. D. Gadola, P. S. Friedmann, and R. Djukanovic. 2007. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 356: 1410-1422.
12. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21: 483-513.
13. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1- specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
14. Park, S. H., and A. Bendelac. 2000. CD1-restricted T-cell responses and microbial infection. Nature 406: 788-792.
15. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
16. Hutloff, A., A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, and R. A. Kroczek. 1999. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 397: 263-266.
17. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409: 105-109.
18. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman, and A. H. Sharpe. 2001. ICOS is critical for CD40- mediated antibody class switching. Nature 409: 102-105.
19. Dong, C, A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101.
20. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigenspecific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032.
21. + T cells. J. Immunol. 165: 5035-5040.
22. Gonzalo, J. A., J. Tian, T. Delaney, J. Corcoran, J. B. Rottman, J. Lora, A. Al-garawi, R. Kroczek, J. C. Gutierrez-Ramos, and A. J. Coyle. 2001. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat. Immunol. 2: 597-604.
23. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 andTh2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018.
24. Fujii, S., K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199: 1607-1618.
25. Uldrich, A. P., N. Y. Crowe, K. Kyparissoudis, D. G. Pellicci, Y. Zhan, A. M. Lew, P. Bouillet, A. Strasser, M. J. Smyth, and D. I. Godfrey. 2005. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J. Immunol. 175: 3092-3101.
26. + T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. J. Immunol. 163: 3083-3091.
27. Van Berkel, M. E., E. H. Schrijver, F. M. Hofhuis, A. H. Sharpe, A. J. Coyle C. P. Broeren, K. Tesselaar, and M. A. Oosterwegel. 2005. ICOS contributes to T cell expansion in CTLA-4 deficient mice. J. Immunol. 175: 182-188.
28. Yang, Y., A. Ueno, M. Bao, Z. Wang, J. S. Im, S. Porcelli, and J. W. Yoon. 2003. Control of NKT cell differentiation by tissue-specific microenvironments. J. Immunol. 171: 5913-5920.
29. Crowe, N. Y., J. M. Coquet, S. P. Berzins, K. Kyparissoudis, R. Keating, D. G. Pellicci, Y. Hayakawa, D. I. Godfrey, and M. J. Smyth. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202: 1279-1288.
30. Seino, K., and M. Taniguchi. 2005. Functionally distinct NKT cell subsets and subtypes. J. Exp. Med. 202: 1623-1626.
31. + invariant NKT cells. Blood 110: 251-258.
32. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
33. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
34. Tupin, E., and M. Kronenberg. 2006. Activation of natural killer T cells by glycolipids. Methods Enzymol. 417: 185-201.
35. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
36. Scheicher, C., M. Mehlig, R. Zecher, and K. Reske. 1992. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154: 253-264.
37. Stockinger, B., and B. Hausmann. 1994. Functional recognition of in vivo processed self antigen. Int. Immunol. 6: 247-254.
38. Hansen, G., G. Berry, R. H. DeKruyff, and D. T Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103: 175-183.
39. Martin, T. R., N. P. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64: 2318-2323.
40. Matsuda, J., L. Gapin, S. Sidobre, W. Kieper, J. Tan, R. Ceredig, C. Surh, and M. Kronenberg. 2002. Homeostasis of Vα14i NKT cells. Nat. Immunol. 3: 966-974.
41. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells secreting IL-10 mediate T cell tolerance induced by respiratory exposure to antigen. Nature Immunol. 2: 725-731.
42. Meyer, E. H., M.-A. Wurbel, T. L. Staton, M. Pichavant, M. J. Kan, P. B. Savage, R. H. DeKruyff, E. C. Butcher, J. J. Campbell, and D. T Umetsu. 2007. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J. Immunol. 179: 4661-4671.
43. Van Berkel, M. E., and M. A. Oosterwegel. 2006. CD28 and ICOS: similar or separate costimulators of T cells? Immunol. Lett. 105: 115-122.
44. Kaneda, H., K. Takeda, T. Ota, Y. Kaduka, H. Akiba, Y. Ikarashi, H. Wakasugi, M. Kronenberg, K. Kinoshita, H. Yagita, and K. Okumura. 2005. ICOS costimulates invariant NKT cell activation. Biochem. Biophys. Res. Commun. 327: 201-207.
45. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of V α 14i NKT cells. Nat. Immunol. 3: 966-974.